VIMTA is a full-service, integrated clinical trials services provider offering Phase II, III, and IV studies. We operate a strong PAN India network of 1500+ GCP-trained investigators across multiple therapeutic areas, supported by in-house expertise in clinical study management to conduct high-quality clinical trials. We also provide exclusive and clinical trial-integrated central laboratory services.
We have established a dedicated laboratory equipped with advanced technologies for developing and delivering bioanalytical methods for biosimilars, including monoclonal antibodies (mAbs). At VIMTA, ethics, subject safety, and regulatory compliance remain our highest priorities, and our experienced scientific team ensures strict adherence to global guidelines at all times.
